Skin Tightening Treatment Market Projected to Witness Vigorous Expansion by 2025

 An expert on premium research reports, Market Research Future has added a report titled "Global Skin Tightening Treatment Market 2023" to its offering.

MarketResearchFuture.com added a new report titled as “Skin Tightening Treatment Market” with forecast to 2025. The study provides details such as the market share of companies in order to present a broader overview of the key players, Market Size, Regional Demand and Industry Revenue – Forecast to 2025

Market Highlights

The Global Skin Tightening Market is forecasted to be valued at USD 6,340.99 Million by 2025 with the CAGR of 6.2% during the forecast period of 2019–2025.

Also Read : https://www.medgadget.com/2019/10/skin-tightening-treatment-market-by-2019-trends-progresses-for-huge-profits-at-usd-6340-99-million-by-global-demand-to-2025.html 

According to International Society of Aesthetic Plastic Surgery (ISAPS), in 2016, estimated the total procedure for skin tightening performed worldwide are 511,481 out of which Japan held the highest number of procedures followed by the US.  The factors that propel the growth of the market are growing geriatric population, increasing advancement in medical technology and the emerging medical aesthetic market.

However, the radiation emitted from skin tightening equipment involve high health-related risk and the stringent government regulations for aesthetic in healthcare is hampering the growth of the skin tightening market.

In the current scenario, several players are dominating the global skin tightening market. The market leaders in skin tightening treatment are involved in merger and acquisition, product development and innovation to increase the foothold in the skin tightening market. For instance, in January 2017, Lynton Lasers launched a stand-alone platform, LUMINA laser & IPL platform, which can perform 24 different aesthetic concern including skin tightening.

Key Players – Skin Tightening Treatment Market

Some of the key players in the global skin tightening market are

• ALLERGAN (US),
• Solta Medical (US),
• Venus Concept (Canada),
• SmarterSkin Dermatology (US),
• INMODE (US),
• Fotona d.o.o. (Slovenia),
• BTL (US),
• Lynton Lasers (UK),
• EINS MED Co., Ltd (South Korea),
• ENDYMED MEDICAL (US), 
• Alma Lasers (Israel)

Segments – Skin Tightening Treatment Market

The global skin tightening market has been segmented based on type, portability, application, end user, and region.

The market, based on type, has been divided into radiofrequency skin tightening, laser skin tightening, ultrasound skin tightening, and others. The radiofrequency skin tightening segment is anticipated to hold the largest share in the market due to the wider preferability and long-lasting results.

The market, based on portability, has been segregated into portable and stand-alone. The stand-alone market is expected to hold the largest share in the market, owing to its increasing application in the medical devices industry.

The market, by application, has been categorized as reduce wrinkles, face lifting, anti-aging, and others. The anti-aging segment is expected to lead the market owing to the increasing focus and concern toward having a youthful appearance.

The market, by end user, has been classified as hospitals & clinics, specialty center, and others. The specialty center segment is anticipated to hold a major share in the market due to the professional skin tightening treatments provided in these establishments.

Regional Analysis – Skin Tightening Treatment Market

The global skin tightening market, by region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The skin tightening market in the Americas is estimated to hold the largest market share. In 2016, according to ISAPS, the total number of skin tightening procedure performed are 75,834. The European skin tightening market has been sub-divided into Western Europe and Eastern Europe. Germany is expected to hold the largest market share in the European region followed by Italy.

The skin tightening market in Asia-Pacific region is expected to be the fastest-growing market, due to increasing research and development funding by the developing countries like China and India for the development of the healthcare sector. The skin tightening market in the Middle East & Africa region has less economic developments and extremely low-income, therefore anticipated to have the least market share but is expected to grow with better opportunities in the coming years.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/skin-tightening-market-8245 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Molecular Diagnostics Market Poised to Witness a Significant Growth by 2023

 This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global XXX Market over the forecast period.

Molecular Diagnostics Market Landscape

After the latest scenario where Coronavirus cases are down, the global molecular diagnostics market repositioned and marked it speedy recovery, leaving behind restrictions imposed during the high cases of the pandemic. On this, Market Research Future reports that the global molecular diagnostics market stocks are streamed, and for the future, the market is going to expand at a rate of 8.57%. At this pace, the rise of the market would take place by generating revenue of USD 16,319.09 Million during the years 2016-2025 (forecasted period).

Also Read : https://www.medgadget.com/2020/08/coronavirus-covid-19-impact-on-molecular-diagnostics-market-share-2020-research-report-global-size-upcoming-trends-industry-growth-key-companies-new-developments-demand-in-india.html

Molecular Diagnostics Market Growth Boosters

Molecular diagnostics often offer quantitative measurements that inform every stage of care and enable the triumphant management of various health conditions. Molecular diagnostics tools have benefited the clinical by providing rapid and sensitive approaches for the detection and monitoring of diverse infectious diseases, cancers, and new chronic diseases. Due to these reasons, the market of molecular diagnostics has gained prominence and became more profitable during the pandemic caused by COVID 19.

The elderly population is vulnerable to chronic diseases such as Parkinson’s disease, lung diseases, diabetes, heart disease, and requires molecular diagnostics that will motivate the market growth. As per the Centers for Disease Control and Prevention (CDC), Alzheimer’s disease and Dementia are most common in adults of 60 years and above. Therefore, the developed, as well as developing countries, are facing an age-linked chronic disease burden that will cultivate the molecular diagnostics market growth in the assessment period.

Market Research Future (MRFR) collected data on several factors including implications of COVID 19 Impact on Molecular Diagnostics Market and demographic challenges, showed how it could move forward in the coming years.

Apart from this, the technological advancements in molecular diagnostics are also highly anticipated to considerably boost market growth as they facilitate accuracy, cost-effectiveness, and portability. The commercialization of MinION, an inexpensive and portable sequencer by Nanopore Technologies, is considered appropriate for use in small laboratories and various care facilities, which is probable to boost the market for molecular diagnostics.

On an important note, the rise in the funding by governments and numerous organizations for R&D in molecular diagnostics is also anticipated to foster the demand for molecular testing. Funding plays a pivotal role in the product development process. In the case of point, Accelerate Diagnostics received USD 19.5 million from entities such as Oracle Institutional Partners, Oracle Partners, and the Schuler Family Foundation, to enhance the development and sales of infectious disease in vitro diagnostics tests and tools.

Molecular Diagnostics Market Segment Review

The global molecular diagnostics market has been studied among the segments of product, technique, application, and end-user.

Depending on the product segment, the market includes instruments, reagents & kits, and services & software.

Depending on the technique segment, the market has included isothermal amplification, polymerase chain reaction (PCR), sequencing, hybridization, microarray, and others.

Depending on the application segment, the market has included genetic tests, oncology, infectious diseases, and others.

Depending on the end-user segment, the market includes diagnostic laboratories, hospitals & clinics, and others. The hospitals & clinics segment grabbed a market value of USD 4.078.09 million in 2018.

Molecular Diagnostics Market Regional Framework

The global molecular diagnostics market regionally has been studied among the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are estimated to lead the global molecular diagnostics market during the forecast period attributing to the mounting geriatric population and the availability of advanced healthcare facilities in the region.

The European market for molecular diagnostics might become the second-largest market in the forecast period. The accessibility of funds for research & development and rising support from the government for the life science sector is what will boost the growth of the market in this region.

Asia-Pacific is also probable to be the fastest-growing market owing to upward economies such as India, China, and South Korea emerging as leading destinations for the outsourcing of clinical trials, drug manufacturing, and pathology testing. Besides this, improving healthcare infrastructure has surged the researches to happen rapidly in the region.

The molecular diagnostics market in the region of the Middle East & Africa might witness healthy growth during the review period in support of a lack of awareness of healthcare facilities.

Molecular Diagnostics Market Vendors Landscape

The prominent vendors in the global molecular diagnostics market are

• Hologic Inc.
• F. Hoffmann-La Roche Ltd
• Dickinson and Company
• Becton
• Cepheid
• Siemens
• Abbott Laboratories
• Agilent Technologies
• Thermo Fisher Scientific

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/molecular-diagnostics-market-1171 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Type-1 Diabetes Treatment Market Projected to Witness Vigorous Expansion by 2023

 Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “XXX Market Research Report - Forecast to 2023” Gives industry size, top players and worldwide demand

Type-1 Diabetes Treatment Market: Synopsis

The Global Type-1 Diabetes Treatment Market is projected to grow from USD 5.6 Billion in 2018 to USD 9.6 Billion by 2025, registering a CAGR of 7.9%.

Type-1 diabetes is a chronic condition that requires lifelong medication. The onset of this condition usually occurs in childhood; it also affects obese and aged individuals.

This condition has been directly linked to a sedentary lifestyle, the adoption of which is widespread globally due to various societal, cultural, and economic factors. The rising prevalence of type-1 diabetes is driving the growth of the market.

Strict approvals processes are expected to hamper the growth of this market. However, this may be offset by the growing number of cases per year and increased government assistance for the management of the condition.

Also Read : https://www.medgadget.com/2019/10/type-1-diabetes-treatment-market-2019-size-to-worth-over-usd-9-6-billion-by-2025-by-eli-lilly-merck-pfizer-inc-sanofi-astrazeneca-etc-global-leaders.html

Market USP

The enhanced efficacy of rapid-acting insulin and rising number of specialty treatment centers for type-1 diabetes are aggressively driving the growth of the market.

Key Players: Type-1 Diabetes Treatment Market

• Astellas Pharma (Japan)
• Eli Lilly (US)
• Merck (US)
• Novo Nordisk (Denmark)
• Sanofi (France)
• AstraZeneca (UK)
• Boehringer Ingelheim GmbH (Germany)
• Novartis (Switzerland)
• Pfizer Inc. (US)
• Abbott Laboratories (US)
• Mannkind Corporation (US)
• Braun Melsungen AG (Germany)
• Macrogenics, Inc. (US)
• DiaVacs, Inc. (US)
• Biodel, Inc. (US)

Segments: Type-1 Diabetes Treatment Market

By Product

• Rapid-Acting Insulin: The rapid-acting insulin segment is expected to be the largest and fastest-growing during the review period. Usually taken before the ingestion of food or drink, rapid-action insulin is easy to introduce into the bloodstream and starts acting within 15 minutes of injection. The segment has been further classified as Admelog, Humalog, Novolog, and others.
• Short-Acting Insulin: Also known as regular insulin, it is included in the World Health Organization’s list of essential medicines.
• Medium-Acting Insulin: This growth of this segment is directly proportional to the growth of the short-acting insulin segment as these insulin types are usually taken concurrently.
• Long-Acting Insulin: This is a growing segment as this type of insulin does not have a peak performance time and is equally effective for the entire duration. It is preferred by healthcare agencies due to its low side effects and gradual action. The segment has been further categorized as Lantus, Levemir, and others.
• Others: Ultra long-term insulin and other experimental insulins are covered in this niche market segment. Though currently the smallest segment, it shows tremendous growth potential due to the numerous beneficial effects and limited side effects of these types of insulin. However, the growth of the segment is limited by stringent regulations, a rigorous testing process, and high costs.

By End User

• Hospitals & Clinics: This is the largest and fastest-growing market segment and is projected to grow well beyond the forecast period. Hospitals and clinics are the primary care centers for individuals afflicted with type-1 diabetes; they are also cost-effective. Moreover, in countries with government-funded healthcare and a high prevalence of type-1 diabetes, hospitals and clinics are the main treatment centers, which is driving the growth of the segment.
• Specialty Centers: A more specialized treatment option, specialty centers have mushroomed across the US and are being opened in India and China. This segment is growing due to the increased number of individuals afflicted with the condition and the higher returns on investment from specialty centers as compared to hospitals and clinics.
• Others: The ease of availability and delivery of diabetes medication has led to patients opting for home treatment. The segment also covers old age homes as the geriatric population is highly susceptible to type-1 diabetes. A niche segment, it is expected to grow as awareness regarding the condition increases along with ease of treatment.

Regional Analysis: Type-1 Diabetes Treatment Market

• Americas: The largest market
• Europe
• Asia-Pacific: The fastest-growing regional market.
• Middle East & Africa

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/type-1-diabetes-treatment-market-8199 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Biomarker Tests Market | Worldwide Top key Players Profile Analysis | Forecast till 2023

 Market Research Future adds the “Biomarker Tests Market Research Report - Forecast to 2023” report to their unique collection.

Global Biomarker Tests Market Research Report: Information by Application (Cancer, Cardiovascular, Infectious Diseases, Central Nervous System and others), End User (Pharma & Biotech Companies, Diagnostic Tool Companies, Healthcare IT/Big Data Companies and Clinical Laboratories) and Region (North America, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2025

Biomarker Tests Market Overview

A biomarker or biological marker is a metric for understanding the behavior of a cell. Biomarker tests are preventive measures for the diagnosis of chronic diseases at an early stage.  For instance, high levels of cholesterol can indicate the possibility of a heart attack or the abnormal growth of cells can signify the presence of cancer. Biomarkers are used as endpoints in a clinical trial to ensure its relevant outcome. The global biomarker test market report by Market Research Future (MRFR) contains drivers, challenges, trends, and opportunities for the period of 2019 to 2025 (forecast period).

Also Read : https://www.medgadget.com/2020/03/biomarker-test-industry-analysis-2020-targeted-therapies-to-pave-open-way-for-growth-for-the-global-biomarker-test-market.html

Biomarker Test Market Analysis

The global biomarker test market size is projected to touch USD 24,259 million by 2025. It stood at a value of USD 9,375 million in 2018. The market is touted to register a CAGR of 14.6% over the forecast period.

Inclination of patients towards home healthcare and self-diagnosis, high demand for biological markers in next-generation sequencing technologies, and rising prevalence of targeted therapies are factors expected to drive to market growth. Technological breakthroughs in diagnostic methods and emergence of personalized medicine can open up new avenues of growth. Biomarker tests have been developed for the diagnosis of infectious diseases, cardiovascular diseases, and cancer.

Reports by the National Institute of Environmental Health Sciences (NIEHS) stating the identification and validation of biomarkers, classification of these compounds by specific diseases, and discovery of patients showing signs of diseases when exposed to certain environments are likely to facilitate market growth. Rising prevalence of genetic disorders and development of tests to support clinical decision making can augur well for the global biomarker test market.

But lack of awareness of applications of biomarkers, difficulties in their implementation, and a stringent regulatory framework are factors that can restrain the global biomarker test growth.

Biomarker Tests Market Segmentation

The global biomarker tests market has been segmented into application and end user.

Based on application, the global market is segmented into central nervous system, cancer, cardiovascular, infectious diseases, and others. The cancer segment dominated the market in 2018 due to the growing cases of cancer, the increasing demand for rapid and precise diagnostic tools, and awareness of personalized medicine. According to the World Health Organization (WHO), in 2018, cancer was the second-leading cause of death worldwide. This can trigger the need for cancer biomarker tests which can let patients take preventive measures.

Based on end user, the global market caters to clinical laboratories, pharma & biotech companies, healthcare IT/big data companies, and diagnostic tool companies.

Biomarker Tests Market Regional Analysis

Based on region, the global biomarker tests market is segmented into North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

North America held the lion’s share of the market in 2018 due to higher prevalence of diseases and efforts taken at research and development. Presence of major pharmaceutical majors such as Quest Diagnostics, Abbott, and Thermo Fisher Scientific, Inc., that can ensure a constant steady of demand-supply to customers or end-users can fuel the regional biomarker test growth.

The APAC biomarker test market can amass significant revenues due to increasing incidence of infectious diseases and increasing investments by research and development companies. In addition, the low cost of clinical trials as compared to developed countries can drive the investment rate by market players. Increasing collaborations of universities with pharmaceutical companies is likely to bode well for the market.

Biomarker Tests Market Competition Outlook

GlaxoSmithKline plc, GE Healthcare, Pfizer Inc., Novartis AG, Medtronic plc, F. Hoffmann-La Roche AG, and Quest Diagnostics are prime players operating in the global biomarker test market.

Biomarker Tests Industry News

A discovery of a biomarker able to predict childhood obesity at an early age in pre-school Hispanic children. It was detected at CpG dinucleotides by the differential methylation in saliva. The prediction of childhood obesity can be used prevent the onset of type 2 diabetes, cancer, and high blood pressure.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/biomarker-test-market-3570 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Primary Osteoarthritis Market 2020 - Opportunity, Driving Trends And Deep Study 2023

 Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Primary Osteoarthritis Market Analysis Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Market Highlights

According to the Centers for Disease Control and Prevention (CDC), more than 54 million people in the United States diagnosed with osteoarthritis (OA), it is the most common type of arthritis and a leading cause of disability. Osteoarthritis therapies are commonly administered via the oral route, with a few products being available in topical and transdermal formulations. The global prevalence of osteoarthritis is estimated to be 8.2%. Pfizer has the highest number of completed clinical trials for osteoarthritis, and also leading sponsors for conducting clinical trials for primary osteoarthritis, followed by Sanofi and Merck & Co. Ltd. For instance, in August 2016, Bioventus, a global leader in orthobiologic solutions launched GELSYN-3, a three-injection hyaluronic acid (HA) product for pain relief associated with osteoarthritis (OA) of the knee.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5380

Regional Analysis

The global primary osteoarthritis market consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominate the global primary osteoarthritis market owing to the increasing cases of arthritis in the U.S. and Canada and play a significant role in driving the global primary osteoarthritis market. The U.S. has a substantial lead in the number of osteoarthritis clinical trials globally, followed by Germany and the U.K. Currently, there are two therapies that has been filed for approval with the FDA. The European primary osteoarthritis market is growing at a steady pace and is anticipated to compete with the American market.

Asia Pacific is expected to be the fastest growing region in the primary osteoarthritis market during the forecasted period 2017-2023. In developing countries from Asia Pacific and the Middle East and Africa, the awareness related to age-specific diseases such as osteoarthritis and osteoporosis is increasing rapidly. For instance, in July 2017, Kolon Pharmaceutical got the approval for the World's first cell and gene therapy for knee osteoarthritis in Korea.

Segmentation

The primary osteoarthritis is segmented on the basis of type, diagnosis, treatment, and end-users.

On the basis of the type, the market is segmented into knee osteoarthritis, hand osteoarthritis, neck osteoarthritis, hip osteoarthritis, wrist osteoarthritis, spinal osteoarthritis, shoulder osteoarthritis, and others

On the basis of the product diagnosis, the market is segmented into imaging, joint fluid analysis, and others. The imaging is further classified into divided X-rays, Magnetic resonance imaging (MRI), and others.

On the basis of the treatment, the market is segmented into medication, therapies, surgery, and others. The medication can be classified into analgesics and non-steroidal anti-inflammatory drugs. The analgesics is further classified as acetaminophen, duloxetine, and others. The non-steroidal anti-inflammatory drugs can be further classified into aspirin, ibuprofen, naproxen sodium/ naproxen, and others.

On the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.

Key Players

Some of key the players in the global primary osteoarthritis market are Abbott Laboratories (U.S.), Johnson & Johnson Limited (U.S.), Novartis AG (Switerzland), Pfizer, Inc. (U.S.), and Eli Lilly and Company (U.S.), Abiogen Pharma (Italy),  Ampio pharmaceuticals (U.S.),  BioDelivery Sciences International (U.S.), CrystalGenomics (South Korea), Daiichi Sankyo (Japan), Eli Lilly (U.S.), Horizon Pharma (Republic of Ireland), Iroko Pharmaceuticals (U.S.), Merck & Co. Ltd (U.S.), Nuvo Research (U.S.), Regeneus (Australia), Sanofi (France), SantoSolve (U.S.),  Smith & Nephew (UK), Winston Pharmaceuticals (India).

FOR MORE DETAILS –  https://www.marketresearchfuture.com/reports/primary-osteoarthritis-market-5380 

A High Double-Digit Cagr Projected For Moebius Syndrome Market During 2020-2023

 Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Moebius syndrome Market Analysis Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Market Scenario

Moebius syndrome is a rare neurological condition characterized by paralysis of multiple cranial nerves, and most often the abducens and facial nerves. Signs and symptoms of Moebius include paralysis of the facial muscles, swallowing and choking problems, crossed eyes, bone abnormalities in the hands, speech difficulties, high or cleft palate, excessive drooling, and various others. As per the National Center for Advancing Translational Sciences, abnormality of the voice, masklike facies, Bell's palsy, feeding difficulties in infancy, and open mouth commonly occur in 80%-99% cases of Moebius syndrome.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5407 

According to the U.S National Library of Medicine, Moebius syndrome affects 1 in 50,000 to 1 in 500,000 newborns. It also mentions that the affected individuals lack facial expressions i.e. they cannot smile, or raise their eyebrows.

It is noted that growing public awareness and technological advancements are the key factors driving the Moebius syndrome treatment market. On the technology front, various surgical options have been used for an effective management of symptoms associated with Moebius syndrome such as facial nerve grafting, facial nerve decompression, transposition of the temporalis muscle, and others.

Various other factors such as unmet medical needs, increasing government assistance, rising healthcare expenditure in the developed countries, improving regulatory framework, increasing adoption rate, and rising funding and reimbursement policies are continuously contributing to the growth of the global Moebius syndrome market. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and the hospital care accounted for a share of 32.3%.

Despite these drivers, there are some issues associated with Moebius syndrome market. The complications associated with the available treatments, infections, and injuries caused by surgical devices, and poor healthcare system in low and middle-income countries, may hinder the growth of the market.

It is estimated that the Moebius syndrome market is expected to grow at a CAGR of 6.5% during the forecast period of 2017-2023.

Key Players

Some of key the players in the global moebius syndrome market are Alcon Laboratories, Inc, All Vascular, Pty Ltd., Aspen Surgical Products, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Conmed Corporation, Gray Surgical, Johnson & Johnson Services, Inc., Medtronic, Olympus Corporation, Smith & Nephew plc, TransEnterix Surgical, Inc., Zimmer Biomet Holdings, Inc., and others.

FOR MORE DETAILS –  https://www.marketresearchfuture.com/reports/moebius-syndrome-market-5407 

The Dental Trauma Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2023

 

Market Highlights

During last decade the number of procedures have increased which has influenced the growth of the market positively. Moreover, increasing demand for the better treatment and changing reimbursement policies has boosted the market growth.

Increasing number of patients suffering from different dental diseases have increased the demand different treatments in the market. During the last few years, the dental consumables have changed the treatment scenario. The market is expecting a healthy growth during the next decade. Moreover, well developed technology has supported the growth of the market in this region.

According to the Pew Center on the States, in 2010, Americans spend USD 106 billion on dental care. According to the American Dental Association, in 2010, over 600 million dental procedures were performed which will continuously increase in coming future.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5301

Approximately 75 % of all procedures were diagnostic procedures of which children aged 0–20 accounts for 41% of all procedures.

The global dental trauma market is expected to grow at a CAGR of ~8.6 % during the forecast period 2017-2023.

Regional Analysis

The Americas dominate the global dental trauma market owing to the presence of huge patient population with dental injuries, high healthcare spending, and increasing government support for research & development.   

Europe holds the second largest share of the global dental trauma market as result of increasing focus of various government agencies on the treatment of dental diseases. Moreover, the growing public awareness about dental trauma likely to boost the European market.   

Asia Pacific is the fastest growing dental trauma market across the globe. Japan holds the major share of the regional market due to availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in China and India over the forecasted period.  

The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

Segmentation

The global dental trauma market is segmented on the basis of types, by treatment, and by end user. On the basis of type, it is segmented into tooth fracture, injuries of the periodontal apparatus, and injuries to supporting bone tissues. Tooth fracture is further segmented into enamel infraction, enamel fracture, enamel-dentine fracture, complex fracture of tooth, root fracture of tooth. Injuries of the periodontal apparatus is further segmented into subluxation of the tooth (tooth knocked loose), luxation of the tooth, intrusion of the tooth (tooth jammed into tooth socket), avulsion of the tooth. Injuries to supporting bone tissues is further segmented into fracture of mandibular/maxillary socket wall, fracture of mandibular/maxillary alveolar processes, fracture of mandible/maxilla. Based on the treatment, it is segmented into cosmetic dentistry, laser dentistry, and others. On the basis of end user, it is segmented into dental clinics, dental laboratories, research laboratories, and others.

Key Players

Some of key the players in the market are Patterson Dental (U.S.), Henry Schein (U.S.), Dentsply Sirona (U.S.), 3M (U.S.), Straumann (Switzerland), Danaher Corporation (Switzerland), PLANMECA OY (Finland), Carestream Health, Inc. (U.S.), Biolase Inc (U.S.), KERR Corporation (U.S.), GC orthodontics (Germany), American Orthodontics (U.S.), Zimmer Holdings Inc. (U.S.), Ivoclar Vivadent AG (Liechtenstein), Gentle Dentistry, LLC (U.S.) and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-trauma-market-5301